In this issue of Rheumatic Disease Clinics, guest editors Drs. M. Elaine Husni? and George A. Karpouzas bring their considerable expertise to the topic of Cardiovascular Complications of Chronic Rheumatic Diseases. Top experts in the field cover key topics such as primary and secondary atherosclerotic cardiovascular (ASCVD) risk prevention in the rheumatic disease, pro-thrombotic and pro-atherogenic anti-phospholipid antibodies, recommendations for the use of NSAIDs and CVD risk, and more.
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases: An Integrative, Multiparametric Approach Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases Heart Failure in Rheumatic Disease: Secular Trends and Novel Insights Cardiovascular Disease in Large Vessel Vasculitis: Risks, Controversies, and Management Strategies Venous Thromboembolism in the Inflammatory Rheumatic Diseases Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.